Nephros Inc. to Acquire Med-Tech Services for $10.5M
Ticker: NEPH · Form: 8-K · Filed: May 24, 2024 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | 8-K |
| Filed Date | May 24, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | bullish |
Sentiment: bullish
Topics: acquisition, m&a, earnings-accretive
TL;DR
Nephros buying Med-Tech for $10.5M, closing Q3 2024. Should boost EPS.
AI Summary
Nephros Inc. announced on May 23, 2024, that it has entered into a definitive agreement to acquire all outstanding equity interests of Med-Tech Services, Inc. for an aggregate purchase price of $10.5 million. The transaction is expected to close in the third quarter of 2024, subject to customary closing conditions. This acquisition is anticipated to be accretive to Nephros' earnings per share.
Why It Matters
This acquisition is expected to enhance Nephros' product portfolio and market presence, potentially leading to increased revenue and profitability.
Risk Assessment
Risk Level: medium — Acquisitions carry inherent risks, including integration challenges, potential overpayment, and failure to achieve expected synergies.
Key Numbers
- $10.5M — Acquisition Price (Aggregate purchase price for Med-Tech Services, Inc.)
Key Players & Entities
- Nephros Inc. (company) — Acquiring company
- Med-Tech Services, Inc. (company) — Acquired company
- $10.5 million (dollar_amount) — Aggregate purchase price
- May 23, 2024 (date) — Date of definitive agreement
- third quarter of 2024 (date) — Expected closing period
FAQ
What is the primary strategic rationale behind Nephros Inc.'s acquisition of Med-Tech Services, Inc.?
The filing indicates the acquisition is expected to be accretive to Nephros' earnings per share, suggesting a focus on financial performance enhancement.
What is the total consideration Nephros Inc. is paying for Med-Tech Services, Inc.?
Nephros Inc. is paying an aggregate purchase price of $10.5 million for all outstanding equity interests of Med-Tech Services, Inc.
When is the acquisition of Med-Tech Services, Inc. expected to be completed?
The transaction is expected to close in the third quarter of 2024.
Are there any specific closing conditions mentioned for the acquisition?
Yes, the acquisition is subject to customary closing conditions.
What is the expected impact of the acquisition on Nephros Inc.'s financial performance?
The acquisition is anticipated to be accretive to Nephros' earnings per share.
Filing Stats: 669 words · 3 min read · ~2 pages · Grade level 10.5 · Accepted 2024-05-24 16:05:29
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value NEPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 55KB
- ex10-1.htm (EX-10.1) — 217KB
- 0001493152-24-021342.txt ( ) — 483KB
- neph-20240523.xsd (EX-101.SCH) — 3KB
- neph-20240523_lab.xml (EX-101.LAB) — 33KB
- neph-20240523_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Nephros, Inc. Dated: May 24, 2024 By: /s/ Judy Krandel Judy Krandel Chief Financial Officer